en

PRODUCT DETAIL

BOXARID 14 mg filmom obalené tablety

Code 4989E
MA number 59/0106/23-S
Product Form: tbl flm 84 (3x28)x14 mg (blis.PA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA31 Teriflunomide
Shelf life: 36
Container: blister PA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 16.12.2023
Validity: 16.12.2028
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_BOXARID 14mg filmom obalené tablety_11 2023.pdf  
PIL: PIL_BOXARID 14mg filmom obalené tablety_11 2023.pdf  
Safety feature Yes
Data update: 20.12.2023
eu-flag.png sk-flag.png